This post was written by Angel Smith Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for investors. Amidst a race with its ...

CWA Asset Management Group LLC raised its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 11.9% in ...

Eli Lilly (LLY) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA's determination that ...

"Lilly's next generation subcutaneous obesity treatment seems to be future proofing the company's weight management franchise," argued SA analyst BioCGT Investor. BioCGT expects the company to ...